MiR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma

被引：0
|
作者：
Ibrahim, Rania
Samaan, Sara
Khella, Heba
Ding, Qiang
Evans, Andrew
Lianidou, Evi
Gabril, Manal
Krylov, Sergey
Jewett, Michael
Bjarnason, Georg
Yousef, George
机构：
[1] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[3] London Hlth Sci Ctr, London, ON, Canada
[4] Univ Western Ontario, London, ON, Canada
[5] York Univ, Toronto, ON M3J 2R7, Canada
[6] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
919
引用
收藏
页码：231A / 231A
页数：1
相关论文
共 50 条
  • [1] MiR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma
    Ibrahim, Rania
    Samaan, Sara
    Khella, Heba
    Ding, Qiang
    Evans, Andrew
    Lianidou, Evi
    Gabril, Manal
    Ktylov, Setgey
    Jewett, Michael
    Bjarnason, Georg
    Yousef, George
    LABORATORY INVESTIGATION, 2015, 95 : 231A - 231A
  • [2] miR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma
    Samaan, Sara
    Khella, Heba W. Z.
    Girgis, Andrew
    Scorilas, Andreas
    Lianidou, Evi
    Gabril, Manal
    Krylov, Sergey N.
    Jewett, Michael
    Bjarnason, Georg A.
    El-said, La
    Yousef, George M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (02): : 136 - 144
  • [3] miR-210 (Hypoxia-Responsive) a Marker of Poor Prognosis in Clear Cell Renal Cell Carcinoma
    Romero, V. A. Valera
    Rodriguez, B. A. Walter
    Sobel, M.
    Linehan, W. M.
    Merino, M. J.
    MODERN PATHOLOGY, 2011, 24 : 228A - 229A
  • [4] miR-210 (Hypoxia-Responsive) a Marker of Poor Prognosis in Clear Cell Renal Cell Carcinoma.
    Romero, V. A. Valera
    Rodriguez, B. A. Walter
    Sobel, M.
    Linehan, W. M.
    Merino, M. J.
    LABORATORY INVESTIGATION, 2011, 91 : 228A - 229A
  • [5] Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma
    Iwamoto, Hideto
    Kanda, Yusuke
    Sejima, Takehiro
    Osaki, Mitsuhiko
    Okada, Futoshi
    Takenaka, Atsushi
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (01) : 53 - 58
  • [6] Serum exosomal miR-210 as a potential biomarker for clear cell renal cell carcinoma
    Wang, Xuegang
    Wang, Tao
    Chen, Chenxi
    Wu, Zhun
    Bai, Peide
    Li, Shouchun
    Chen, Bin
    Liu, Rongfu
    Zhang, Kaiyan
    Li, Wei
    Chen, Yuedong
    Xing, Jinchun
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (02) : 1492 - 1502
  • [7] Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma
    Zhao, An
    Li, Guorong
    Peoc'h, Michel
    Genin, Christian
    Gigante, Marc
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 94 (01) : 115 - 120
  • [8] Extracellular miR-224 as a prognostic marker for clear cell renal cell carcinoma
    Fujii, Nakanori
    Hirata, Hiroshi
    Ueno, Koji
    Mori, Junichi
    Oka, Shintaro
    Shimizu, Kosuke
    Kawai, Yoshihisa
    Inoue, Ryo
    Yamamoto, Yoshiaki
    Matsumoto, Hiroaki
    Shimabukuro, Tomoyuki
    Udoh, Koichi
    Hoshii, Yoshinobu
    Dahiya, Rajvir
    Matsuyama, Hideyasu
    ONCOTARGET, 2017, 8 (66) : 109877 - 109888
  • [9] miR-10b is a prognostic marker in clear cell renal cell carcinoma
    Khella, Heba W. Z.
    Daniel, Nicole
    Youssef, Leza
    Scorilas, Andreas
    Nofech-Mozes, Roy
    Mirham, Lorna
    Krylov, Sergey N.
    Liandeau, Evi
    Krizova, Adriana
    Finelli, Antonio
    Cheng, Yufeng
    Yousef, George M.
    JOURNAL OF CLINICAL PATHOLOGY, 2017, 70 (10) : 854 - 859
  • [10] Detection of urinary cell-free miR-210 as a potential tool of liquid biopsy for clear cell renal cell carcinoma
    Li, Guorong
    Zhao, An
    Peoch, Michel
    Cottier, Michele
    Mottet, Nicolas
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (05) : 294 - 299
12345